QRxPharma Pty Ltd. Sets PDUFA Date for MOXDUO® NDA
3/14/2013 7:59:50 AM
More...
|
QRxPharma Pty Ltd. Resubmits MOXDUO® New Drug Application to the FDA
2/28/2013 11:02:06 AM
More...
|
QRxPharma Pty Ltd. and FDA Establish Path Forward for Resubmission of MOXDUO® New Drug Application
1/16/2013 9:23:35 AM
More...
|
Paladin Labs Inc. (CC:PLB) Announces Agreement With QRxPharma Pty Ltd. for Up to $25 Million
10/10/2012 7:14:34 AM
More...
|
QRxPharma Pty Ltd. Granted Additional US Patent on MoxDuo®
5/23/2012 11:50:57 AM
More...
|
QRxPharma Pty Ltd. Successfully Completes Phase 1 Studies for MoxDuo® CR
4/11/2012 8:40:37 AM
More...
|
QRxPharma Pty Ltd. Signs License and Option Agreement With Actavis
3/19/2012 7:36:37 AM
More...
|
QRxPharma Pty Ltd. to Present at the 32nd Cowen and Company Health Care Conference
3/2/2012 11:37:25 AM
More...
|
QRxPharma Pty Ltd. Announces Strategic Partnership with Actavis
12/21/2011 7:32:10 AM
More...
|
DSM Pharmaceutical Products Signs Contract with QRxPharma Pty Ltd. to Produce MoxDuo® Capsules
12/13/2011 2:17:37 PM
More...
|
|